Read why we think NGL preferred shares are a strong buy with 12%+ yields, improved fundamentals, and low call risk.

As for Seralutinib’s PH-ILD indication, the SERANATA Phase 3 trial will begin site activations in Q4 2025. GOSS has enough ...

The Lenovo Yoga 32i all-in-one desktop stays near the top of its game with a stunning design, wireless charging, and a vivid ...

The India Team won 4 golds and one silver at the International Olympiad on Astronomy and Astrophysics (IOAA) held this year, ...